Coblopasvir dihydrochloride

CAS No. 1966138-53-3

Coblopasvir dihydrochloride( Coblopasvir dihydrochloride(1312608-46-0 Free base) )

Catalog No. M27811 CAS No. 1966138-53-3

Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Coblopasvir dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
  • Description
    Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Coblopasvir dihydrochloride(1312608-46-0 Free base)
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    5-HT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1966138-53-3
  • Formula Weight
    855.81
  • Molecular Formula
    C41H52Cl2N8O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (58.42 mM)
  • SMILES
    O=C(OC)N[C@@H](C(N1[C@@H](C2=NC=C(C3=CC=C(C4=C5OCOC5=C(C6=CN=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC7)N6)C=C4)C=C3)N2)CCC1)=O)C(C)C.[H]Cl.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8.
molnova catalog
related products
  • Pibrentasvir

    Pibrentasvir (ABT-530) is a novel and pan-genotypic HCV NS5A inhibitor with EC50 of 1.4-5.0 pM against HCV replicons containing NS5A genotypes 1-6.

  • VCH-916

    VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.

  • Betaxolol

    Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.